Insights

Market traction X-Therma is rapidly expanding in biopreservation for cell therapies and organ preservation, with recent end-to-end systems launching to extend storage from hours to five days, signaling growing demand among regenerative medicine players and biopharma manufacturers.

Strategic partnerships Recent board addition of a healthcare entrepreneur and high-profile industry events (Johns Hopkins on the Hill, Kidney Health campaigns) indicate a push toward strategic collaborations with academic centers, transplantation programs, and biotech incumbents to accelerate adoption.

Funding momentum The company has raised substantial capital (Series A and B totaling over 37 million) and maintains ongoing investor interest, suggesting readiness to scale manufacturing, clinical development, and global distribution for biopreservation technologies.

Technology moat Convergent biomimetic nanotechnology and ice-interactive biomaterials position X-Therma with a differentiated preservation platform capable of reducing toxic additives and cold-chain dependencies, addressing a critical bottleneck in cell therapies, organ preservation, and biobanking.

Industry fit Customer segments include regenerative medicine startups, biopharma, organ donation programs, and research institutions; cross-selling opportunities exist across storage, transport, and end-to-end preservation platforms as demand grows for scalable biobanking.

Similar companies to X-Therma Inc.

X-Therma Inc. Tech Stack

X-Therma Inc. uses 8 technology products and services including Linkedin Insight Tag, Microsoft Clarity, SOLIDWORKS, and more. Explore X-Therma Inc.'s tech stack below.

Media & News

X-Therma Inc.'s Email Address Formats

X-Therma Inc. uses at least 4 email formats:
X-Therma Inc. Email FormatsExamplePercentage
FLast@x-therma.comJDoe@x-therma.com
72%
LFirst@x-therma.comDJohn@x-therma.com
20%
Last@x-therma.comDoe@x-therma.com
5%
FirstLast@x-therma.comJohnDoe@x-therma.com
3%

Frequently Asked Questions

What is X-Therma Inc.'s official website and social media links?

Minus sign iconPlus sign icon
X-Therma Inc.'s official website is x-therma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does X-Therma Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, X-Therma Inc.'s annual revenue is estimated to be $10M - $25M.

What is X-Therma Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
X-Therma Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does X-Therma Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, X-Therma Inc. has approximately 31 employees across 3 continents, including North America, Asia and Europe. Key team members include Chief Technology Officer And Chief Operating Officer: M. K., Chief Financial Officer: J. W. and Senior Vice President, Commercial: M. O. Explore X-Therma Inc.'s employee directory with LeadIQ.

What industry does X-Therma Inc. belong to?

Minus sign iconPlus sign icon
X-Therma Inc. operates in the Biotechnology Research industry.

What technology does X-Therma Inc. use?

Minus sign iconPlus sign icon
X-Therma Inc.'s tech stack includes Linkedin Insight Tag, Microsoft Clarity, SOLIDWORKS, WordPress, CookieYes, Microsoft 365, Microsoft Teams and Adobe Creative Suite.

What is X-Therma Inc.'s email format?

Minus sign iconPlus sign icon
X-Therma Inc.'s email format typically follows the pattern of FLast@x-therma.com. Find more X-Therma Inc. email formats with LeadIQ.

How much funding has X-Therma Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, X-Therma Inc. has raised $37M in funding. The last funding round occurred on Mar 13, 2024 for $22M.

When was X-Therma Inc. founded?

Minus sign iconPlus sign icon
X-Therma Inc. was founded in 2014.
X-Therma Inc. logo

X-Therma Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

X-Therma Inc. is a biotechnology company dedicated to improving the storage and transport of biological products through convergent biomimetic nanotechnology. The technology is aimed at strengthening biopreservation for regenerative medicine, supporting long-term biobanking and safer handling in areas like advanced cell therapies, IVF, and organ transplants. Based in Hercules, California, the company sits within the biotechnology research industry and focuses on solutions that address storage and transport challenges in biomanufacturing and related research settings.

In 2026, X-Therma launched a cold chain platform for cell therapies, marking a concrete product-focused advancement. The development demonstrates progress toward practical applications for industry stakeholders and aligns with the company’s focus on biopreservation in regenerative medicine.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $37M

    X-Therma Inc. has raised a total of $37M of funding over 5 rounds. Their latest funding round was raised on Mar 13, 2024 in the amount of $22M as a Series B.

  • $10M - $25M

    X-Therma Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.